Global Toxoplasma Gondii Recombinant Antigen Market Growth (Status and Outlook) 2026-2032
The global Toxoplasma Gondii Recombinant Antigen market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Toxoplasma Gondii Recombinant Antigen is a protein produced by genetic engineering technology that mimics the natural antigen of Toxoplasma gondii. Toxoplasma gondii is a parasite that causes toxoplasmosis in humans and animals. Recombinant antigens are used in in vitro diagnostic reagents to detect immune responses caused by Toxoplasma infection, such as the presence of antibodies. By using recombinant antigens, the specificity and sensitivity of diagnosis can be improved and cross-reactions and non-specific reactions can be reduced.
United States market for Toxoplasma Gondii Recombinant Antigen is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Toxoplasma Gondii Recombinant Antigen is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Toxoplasma Gondii Recombinant Antigen is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Toxoplasma Gondii Recombinant Antigen players cover Rekom Biotech, Roche, Thermal Fisher, Bio-Rad, Abcam, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Toxoplasma Gondii Recombinant Antigen Industry Forecast” looks at past sales and reviews total world Toxoplasma Gondii Recombinant Antigen sales in 2025, providing a comprehensive analysis by region and market sector of projected Toxoplasma Gondii Recombinant Antigen sales for 2026 through 2032. With Toxoplasma Gondii Recombinant Antigen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Toxoplasma Gondii Recombinant Antigen industry.
This Insight Report provides a comprehensive analysis of the global Toxoplasma Gondii Recombinant Antigen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Toxoplasma Gondii Recombinant Antigen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Toxoplasma Gondii Recombinant Antigen market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Toxoplasma Gondii Recombinant Antigen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Toxoplasma Gondii Recombinant Antigen.
This report presents a comprehensive overview, market shares, and growth opportunities of Toxoplasma Gondii Recombinant Antigen market by product type, application, key players and key regions and countries.
Segmentation by Type:
Toxoplasma Gondii Recombinant Antigen is a protein produced by genetic engineering technology that mimics the natural antigen of Toxoplasma gondii. Toxoplasma gondii is a parasite that causes toxoplasmosis in humans and animals. Recombinant antigens are used in in vitro diagnostic reagents to detect immune responses caused by Toxoplasma infection, such as the presence of antibodies. By using recombinant antigens, the specificity and sensitivity of diagnosis can be improved and cross-reactions and non-specific reactions can be reduced.
United States market for Toxoplasma Gondii Recombinant Antigen is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Toxoplasma Gondii Recombinant Antigen is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Toxoplasma Gondii Recombinant Antigen is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Toxoplasma Gondii Recombinant Antigen players cover Rekom Biotech, Roche, Thermal Fisher, Bio-Rad, Abcam, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Toxoplasma Gondii Recombinant Antigen Industry Forecast” looks at past sales and reviews total world Toxoplasma Gondii Recombinant Antigen sales in 2025, providing a comprehensive analysis by region and market sector of projected Toxoplasma Gondii Recombinant Antigen sales for 2026 through 2032. With Toxoplasma Gondii Recombinant Antigen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Toxoplasma Gondii Recombinant Antigen industry.
This Insight Report provides a comprehensive analysis of the global Toxoplasma Gondii Recombinant Antigen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Toxoplasma Gondii Recombinant Antigen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Toxoplasma Gondii Recombinant Antigen market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Toxoplasma Gondii Recombinant Antigen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Toxoplasma Gondii Recombinant Antigen.
This report presents a comprehensive overview, market shares, and growth opportunities of Toxoplasma Gondii Recombinant Antigen market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Full-Length Antigen
- Truncated Antigen
- In Vitro Diagnostics
- Vaccine Development
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Rekom Biotech
- Roche
- Thermal Fisher
- Bio-Rad
- Abcam
- Meridian Bioscience
- Fapon Biotech
- ViroGen Corporation
- Medix Biochemica
- Creative Diagnostics
- Prospec
- Cusabio
- Abbexa
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Toxoplasma Gondii Recombinant Antigen Market Size (2021-2032)
2.1.2 Toxoplasma Gondii Recombinant Antigen Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Toxoplasma Gondii Recombinant Antigen by Country/Region (2021, 2025 & 2032)
2.2 Toxoplasma Gondii Recombinant Antigen Segment by Type
2.2.1 Full-Length Antigen
2.2.2 Truncated Antigen
2.2.3 Toxoplasma Gondii Recombinant Antigen Market Size by Type
2.2.3.1 Toxoplasma Gondii Recombinant Antigen Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type (2021-2026)
2.3 Toxoplasma Gondii Recombinant Antigen Segment by Application
2.3.1 In Vitro Diagnostics
2.3.2 Vaccine Development
2.3.3 Others
2.3.4 Toxoplasma Gondii Recombinant Antigen Market Size by Application
2.3.4.1 Toxoplasma Gondii Recombinant Antigen Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application (2021-2026)
3 TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE BY PLAYER
3.1 Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Player
3.1.1 Global Toxoplasma Gondii Recombinant Antigen Revenue by Player (2021-2026)
3.1.2 Global Toxoplasma Gondii Recombinant Antigen Revenue Market Share by Player (2021-2026)
3.2 Global Toxoplasma Gondii Recombinant Antigen Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TOXOPLASMA GONDII RECOMBINANT ANTIGEN BY REGION
4.1 Toxoplasma Gondii Recombinant Antigen Market Size by Region (2021-2026)
4.2 Global Toxoplasma Gondii Recombinant Antigen Annual Revenue by Country/Region (2021-2026)
4.3 Americas Toxoplasma Gondii Recombinant Antigen Market Size Growth (2021-2026)
4.4 APAC Toxoplasma Gondii Recombinant Antigen Market Size Growth (2021-2026)
4.5 Europe Toxoplasma Gondii Recombinant Antigen Market Size Growth (2021-2026)
4.6 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Toxoplasma Gondii Recombinant Antigen Market Size by Country (2021-2026)
5.2 Americas Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026)
5.3 Americas Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Toxoplasma Gondii Recombinant Antigen Market Size by Region (2021-2026)
6.2 APAC Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026)
6.3 APAC Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Toxoplasma Gondii Recombinant Antigen Market Size by Country (2021-2026)
7.2 Europe Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026)
7.3 Europe Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Toxoplasma Gondii Recombinant Antigen by Region (2021-2026)
8.2 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026)
8.3 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET FORECAST
10.1 Global Toxoplasma Gondii Recombinant Antigen Forecast by Region (2027-2032)
10.1.1 Global Toxoplasma Gondii Recombinant Antigen Forecast by Region (2027-2032)
10.1.2 Americas Toxoplasma Gondii Recombinant Antigen Forecast
10.1.3 APAC Toxoplasma Gondii Recombinant Antigen Forecast
10.1.4 Europe Toxoplasma Gondii Recombinant Antigen Forecast
10.1.5 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Forecast
10.2 Americas Toxoplasma Gondii Recombinant Antigen Forecast by Country (2027-2032)
10.2.1 United States Market Toxoplasma Gondii Recombinant Antigen Forecast
10.2.2 Canada Market Toxoplasma Gondii Recombinant Antigen Forecast
10.2.3 Mexico Market Toxoplasma Gondii Recombinant Antigen Forecast
10.2.4 Brazil Market Toxoplasma Gondii Recombinant Antigen Forecast
10.3 APAC Toxoplasma Gondii Recombinant Antigen Forecast by Region (2027-2032)
10.3.1 China Toxoplasma Gondii Recombinant Antigen Market Forecast
10.3.2 Japan Market Toxoplasma Gondii Recombinant Antigen Forecast
10.3.3 Korea Market Toxoplasma Gondii Recombinant Antigen Forecast
10.3.4 Southeast Asia Market Toxoplasma Gondii Recombinant Antigen Forecast
10.3.5 India Market Toxoplasma Gondii Recombinant Antigen Forecast
10.3.6 Australia Market Toxoplasma Gondii Recombinant Antigen Forecast
10.4 Europe Toxoplasma Gondii Recombinant Antigen Forecast by Country (2027-2032)
10.4.1 Germany Market Toxoplasma Gondii Recombinant Antigen Forecast
10.4.2 France Market Toxoplasma Gondii Recombinant Antigen Forecast
10.4.3 UK Market Toxoplasma Gondii Recombinant Antigen Forecast
10.4.4 Italy Market Toxoplasma Gondii Recombinant Antigen Forecast
10.4.5 Russia Market Toxoplasma Gondii Recombinant Antigen Forecast
10.5 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Forecast by Region (2027-2032)
10.5.1 Egypt Market Toxoplasma Gondii Recombinant Antigen Forecast
10.5.2 South Africa Market Toxoplasma Gondii Recombinant Antigen Forecast
10.5.3 Israel Market Toxoplasma Gondii Recombinant Antigen Forecast
10.5.4 Turkey Market Toxoplasma Gondii Recombinant Antigen Forecast
10.6 Global Toxoplasma Gondii Recombinant Antigen Forecast by Type (2027-2032)
10.7 Global Toxoplasma Gondii Recombinant Antigen Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Toxoplasma Gondii Recombinant Antigen Forecast
11 KEY PLAYERS ANALYSIS
11.1 Rekom Biotech
11.1.1 Rekom Biotech Company Information
11.1.2 Rekom Biotech Toxoplasma Gondii Recombinant Antigen Product Offered
11.1.3 Rekom Biotech Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Rekom Biotech Main Business Overview
11.1.5 Rekom Biotech Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Toxoplasma Gondii Recombinant Antigen Product Offered
11.2.3 Roche Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Thermal Fisher
11.3.1 Thermal Fisher Company Information
11.3.2 Thermal Fisher Toxoplasma Gondii Recombinant Antigen Product Offered
11.3.3 Thermal Fisher Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Thermal Fisher Main Business Overview
11.3.5 Thermal Fisher Latest Developments
11.4 Bio-Rad
11.4.1 Bio-Rad Company Information
11.4.2 Bio-Rad Toxoplasma Gondii Recombinant Antigen Product Offered
11.4.3 Bio-Rad Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bio-Rad Main Business Overview
11.4.5 Bio-Rad Latest Developments
11.5 Abcam
11.5.1 Abcam Company Information
11.5.2 Abcam Toxoplasma Gondii Recombinant Antigen Product Offered
11.5.3 Abcam Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Abcam Main Business Overview
11.5.5 Abcam Latest Developments
11.6 Meridian Bioscience
11.6.1 Meridian Bioscience Company Information
11.6.2 Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Product Offered
11.6.3 Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Meridian Bioscience Main Business Overview
11.6.5 Meridian Bioscience Latest Developments
11.7 Fapon Biotech
11.7.1 Fapon Biotech Company Information
11.7.2 Fapon Biotech Toxoplasma Gondii Recombinant Antigen Product Offered
11.7.3 Fapon Biotech Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Fapon Biotech Main Business Overview
11.7.5 Fapon Biotech Latest Developments
11.8 ViroGen Corporation
11.8.1 ViroGen Corporation Company Information
11.8.2 ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Product Offered
11.8.3 ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 ViroGen Corporation Main Business Overview
11.8.5 ViroGen Corporation Latest Developments
11.9 Medix Biochemica
11.9.1 Medix Biochemica Company Information
11.9.2 Medix Biochemica Toxoplasma Gondii Recombinant Antigen Product Offered
11.9.3 Medix Biochemica Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Medix Biochemica Main Business Overview
11.9.5 Medix Biochemica Latest Developments
11.10 Creative Diagnostics
11.10.1 Creative Diagnostics Company Information
11.10.2 Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Product Offered
11.10.3 Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Creative Diagnostics Main Business Overview
11.10.5 Creative Diagnostics Latest Developments
11.11 Prospec
11.11.1 Prospec Company Information
11.11.2 Prospec Toxoplasma Gondii Recombinant Antigen Product Offered
11.11.3 Prospec Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Prospec Main Business Overview
11.11.5 Prospec Latest Developments
11.12 Cusabio
11.12.1 Cusabio Company Information
11.12.2 Cusabio Toxoplasma Gondii Recombinant Antigen Product Offered
11.12.3 Cusabio Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Cusabio Main Business Overview
11.12.5 Cusabio Latest Developments
11.13 Abbexa
11.13.1 Abbexa Company Information
11.13.2 Abbexa Toxoplasma Gondii Recombinant Antigen Product Offered
11.13.3 Abbexa Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Abbexa Main Business Overview
11.13.5 Abbexa Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Toxoplasma Gondii Recombinant Antigen Market Size (2021-2032)
2.1.2 Toxoplasma Gondii Recombinant Antigen Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Toxoplasma Gondii Recombinant Antigen by Country/Region (2021, 2025 & 2032)
2.2 Toxoplasma Gondii Recombinant Antigen Segment by Type
2.2.1 Full-Length Antigen
2.2.2 Truncated Antigen
2.2.3 Toxoplasma Gondii Recombinant Antigen Market Size by Type
2.2.3.1 Toxoplasma Gondii Recombinant Antigen Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type (2021-2026)
2.3 Toxoplasma Gondii Recombinant Antigen Segment by Application
2.3.1 In Vitro Diagnostics
2.3.2 Vaccine Development
2.3.3 Others
2.3.4 Toxoplasma Gondii Recombinant Antigen Market Size by Application
2.3.4.1 Toxoplasma Gondii Recombinant Antigen Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application (2021-2026)
3 TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE BY PLAYER
3.1 Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Player
3.1.1 Global Toxoplasma Gondii Recombinant Antigen Revenue by Player (2021-2026)
3.1.2 Global Toxoplasma Gondii Recombinant Antigen Revenue Market Share by Player (2021-2026)
3.2 Global Toxoplasma Gondii Recombinant Antigen Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TOXOPLASMA GONDII RECOMBINANT ANTIGEN BY REGION
4.1 Toxoplasma Gondii Recombinant Antigen Market Size by Region (2021-2026)
4.2 Global Toxoplasma Gondii Recombinant Antigen Annual Revenue by Country/Region (2021-2026)
4.3 Americas Toxoplasma Gondii Recombinant Antigen Market Size Growth (2021-2026)
4.4 APAC Toxoplasma Gondii Recombinant Antigen Market Size Growth (2021-2026)
4.5 Europe Toxoplasma Gondii Recombinant Antigen Market Size Growth (2021-2026)
4.6 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Toxoplasma Gondii Recombinant Antigen Market Size by Country (2021-2026)
5.2 Americas Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026)
5.3 Americas Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Toxoplasma Gondii Recombinant Antigen Market Size by Region (2021-2026)
6.2 APAC Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026)
6.3 APAC Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Toxoplasma Gondii Recombinant Antigen Market Size by Country (2021-2026)
7.2 Europe Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026)
7.3 Europe Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Toxoplasma Gondii Recombinant Antigen by Region (2021-2026)
8.2 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026)
8.3 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET FORECAST
10.1 Global Toxoplasma Gondii Recombinant Antigen Forecast by Region (2027-2032)
10.1.1 Global Toxoplasma Gondii Recombinant Antigen Forecast by Region (2027-2032)
10.1.2 Americas Toxoplasma Gondii Recombinant Antigen Forecast
10.1.3 APAC Toxoplasma Gondii Recombinant Antigen Forecast
10.1.4 Europe Toxoplasma Gondii Recombinant Antigen Forecast
10.1.5 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Forecast
10.2 Americas Toxoplasma Gondii Recombinant Antigen Forecast by Country (2027-2032)
10.2.1 United States Market Toxoplasma Gondii Recombinant Antigen Forecast
10.2.2 Canada Market Toxoplasma Gondii Recombinant Antigen Forecast
10.2.3 Mexico Market Toxoplasma Gondii Recombinant Antigen Forecast
10.2.4 Brazil Market Toxoplasma Gondii Recombinant Antigen Forecast
10.3 APAC Toxoplasma Gondii Recombinant Antigen Forecast by Region (2027-2032)
10.3.1 China Toxoplasma Gondii Recombinant Antigen Market Forecast
10.3.2 Japan Market Toxoplasma Gondii Recombinant Antigen Forecast
10.3.3 Korea Market Toxoplasma Gondii Recombinant Antigen Forecast
10.3.4 Southeast Asia Market Toxoplasma Gondii Recombinant Antigen Forecast
10.3.5 India Market Toxoplasma Gondii Recombinant Antigen Forecast
10.3.6 Australia Market Toxoplasma Gondii Recombinant Antigen Forecast
10.4 Europe Toxoplasma Gondii Recombinant Antigen Forecast by Country (2027-2032)
10.4.1 Germany Market Toxoplasma Gondii Recombinant Antigen Forecast
10.4.2 France Market Toxoplasma Gondii Recombinant Antigen Forecast
10.4.3 UK Market Toxoplasma Gondii Recombinant Antigen Forecast
10.4.4 Italy Market Toxoplasma Gondii Recombinant Antigen Forecast
10.4.5 Russia Market Toxoplasma Gondii Recombinant Antigen Forecast
10.5 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Forecast by Region (2027-2032)
10.5.1 Egypt Market Toxoplasma Gondii Recombinant Antigen Forecast
10.5.2 South Africa Market Toxoplasma Gondii Recombinant Antigen Forecast
10.5.3 Israel Market Toxoplasma Gondii Recombinant Antigen Forecast
10.5.4 Turkey Market Toxoplasma Gondii Recombinant Antigen Forecast
10.6 Global Toxoplasma Gondii Recombinant Antigen Forecast by Type (2027-2032)
10.7 Global Toxoplasma Gondii Recombinant Antigen Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Toxoplasma Gondii Recombinant Antigen Forecast
11 KEY PLAYERS ANALYSIS
11.1 Rekom Biotech
11.1.1 Rekom Biotech Company Information
11.1.2 Rekom Biotech Toxoplasma Gondii Recombinant Antigen Product Offered
11.1.3 Rekom Biotech Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Rekom Biotech Main Business Overview
11.1.5 Rekom Biotech Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Toxoplasma Gondii Recombinant Antigen Product Offered
11.2.3 Roche Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Thermal Fisher
11.3.1 Thermal Fisher Company Information
11.3.2 Thermal Fisher Toxoplasma Gondii Recombinant Antigen Product Offered
11.3.3 Thermal Fisher Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Thermal Fisher Main Business Overview
11.3.5 Thermal Fisher Latest Developments
11.4 Bio-Rad
11.4.1 Bio-Rad Company Information
11.4.2 Bio-Rad Toxoplasma Gondii Recombinant Antigen Product Offered
11.4.3 Bio-Rad Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bio-Rad Main Business Overview
11.4.5 Bio-Rad Latest Developments
11.5 Abcam
11.5.1 Abcam Company Information
11.5.2 Abcam Toxoplasma Gondii Recombinant Antigen Product Offered
11.5.3 Abcam Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Abcam Main Business Overview
11.5.5 Abcam Latest Developments
11.6 Meridian Bioscience
11.6.1 Meridian Bioscience Company Information
11.6.2 Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Product Offered
11.6.3 Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Meridian Bioscience Main Business Overview
11.6.5 Meridian Bioscience Latest Developments
11.7 Fapon Biotech
11.7.1 Fapon Biotech Company Information
11.7.2 Fapon Biotech Toxoplasma Gondii Recombinant Antigen Product Offered
11.7.3 Fapon Biotech Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Fapon Biotech Main Business Overview
11.7.5 Fapon Biotech Latest Developments
11.8 ViroGen Corporation
11.8.1 ViroGen Corporation Company Information
11.8.2 ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Product Offered
11.8.3 ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 ViroGen Corporation Main Business Overview
11.8.5 ViroGen Corporation Latest Developments
11.9 Medix Biochemica
11.9.1 Medix Biochemica Company Information
11.9.2 Medix Biochemica Toxoplasma Gondii Recombinant Antigen Product Offered
11.9.3 Medix Biochemica Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Medix Biochemica Main Business Overview
11.9.5 Medix Biochemica Latest Developments
11.10 Creative Diagnostics
11.10.1 Creative Diagnostics Company Information
11.10.2 Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Product Offered
11.10.3 Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Creative Diagnostics Main Business Overview
11.10.5 Creative Diagnostics Latest Developments
11.11 Prospec
11.11.1 Prospec Company Information
11.11.2 Prospec Toxoplasma Gondii Recombinant Antigen Product Offered
11.11.3 Prospec Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Prospec Main Business Overview
11.11.5 Prospec Latest Developments
11.12 Cusabio
11.12.1 Cusabio Company Information
11.12.2 Cusabio Toxoplasma Gondii Recombinant Antigen Product Offered
11.12.3 Cusabio Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Cusabio Main Business Overview
11.12.5 Cusabio Latest Developments
11.13 Abbexa
11.13.1 Abbexa Company Information
11.13.2 Abbexa Toxoplasma Gondii Recombinant Antigen Product Offered
11.13.3 Abbexa Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Abbexa Main Business Overview
11.13.5 Abbexa Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Toxoplasma Gondii Recombinant Antigen Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Toxoplasma Gondii Recombinant Antigen Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Full-Length Antigen
Table 4. Major Players of Truncated Antigen
Table 5. Toxoplasma Gondii Recombinant Antigen Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type (2021-2026)
Table 8. Toxoplasma Gondii Recombinant Antigen Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application (2021-2026)
Table 11. Global Toxoplasma Gondii Recombinant Antigen Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Toxoplasma Gondii Recombinant Antigen Revenue Market Share by Player (2021-2026)
Table 13. Toxoplasma Gondii Recombinant Antigen Key Players Head office and Products Offered
Table 14. Toxoplasma Gondii Recombinant Antigen Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Toxoplasma Gondii Recombinant Antigen Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Region (2021-2026)
Table 19. Global Toxoplasma Gondii Recombinant Antigen Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Toxoplasma Gondii Recombinant Antigen Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Toxoplasma Gondii Recombinant Antigen Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Country (2021-2026)
Table 23. Americas Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type (2021-2026)
Table 25. Americas Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application (2021-2026)
Table 27. APAC Toxoplasma Gondii Recombinant Antigen Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Region (2021-2026)
Table 29. APAC Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Toxoplasma Gondii Recombinant Antigen Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Country (2021-2026)
Table 33. Europe Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Toxoplasma Gondii Recombinant Antigen
Table 39. Key Market Challenges & Risks of Toxoplasma Gondii Recombinant Antigen
Table 40. Key Industry Trends of Toxoplasma Gondii Recombinant Antigen
Table 41. Global Toxoplasma Gondii Recombinant Antigen Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Toxoplasma Gondii Recombinant Antigen Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Toxoplasma Gondii Recombinant Antigen Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Rekom Biotech Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 46. Rekom Biotech Toxoplasma Gondii Recombinant Antigen Product Offered
Table 47. Rekom Biotech Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Rekom Biotech Main Business
Table 49. Rekom Biotech Latest Developments
Table 50. Roche Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 51. Roche Toxoplasma Gondii Recombinant Antigen Product Offered
Table 52. Roche Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Roche Main Business
Table 54. Roche Latest Developments
Table 55. Thermal Fisher Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 56. Thermal Fisher Toxoplasma Gondii Recombinant Antigen Product Offered
Table 57. Thermal Fisher Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Thermal Fisher Main Business
Table 59. Thermal Fisher Latest Developments
Table 60. Bio-Rad Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 61. Bio-Rad Toxoplasma Gondii Recombinant Antigen Product Offered
Table 62. Bio-Rad Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Bio-Rad Main Business
Table 64. Bio-Rad Latest Developments
Table 65. Abcam Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 66. Abcam Toxoplasma Gondii Recombinant Antigen Product Offered
Table 67. Abcam Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Abcam Main Business
Table 69. Abcam Latest Developments
Table 70. Meridian Bioscience Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 71. Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Product Offered
Table 72. Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Meridian Bioscience Main Business
Table 74. Meridian Bioscience Latest Developments
Table 75. Fapon Biotech Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 76. Fapon Biotech Toxoplasma Gondii Recombinant Antigen Product Offered
Table 77. Fapon Biotech Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Fapon Biotech Main Business
Table 79. Fapon Biotech Latest Developments
Table 80. ViroGen Corporation Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 81. ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Product Offered
Table 82. ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. ViroGen Corporation Main Business
Table 84. ViroGen Corporation Latest Developments
Table 85. Medix Biochemica Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 86. Medix Biochemica Toxoplasma Gondii Recombinant Antigen Product Offered
Table 87. Medix Biochemica Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Medix Biochemica Main Business
Table 89. Medix Biochemica Latest Developments
Table 90. Creative Diagnostics Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 91. Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Product Offered
Table 92. Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Creative Diagnostics Main Business
Table 94. Creative Diagnostics Latest Developments
Table 95. Prospec Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 96. Prospec Toxoplasma Gondii Recombinant Antigen Product Offered
Table 97. Prospec Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Prospec Main Business
Table 99. Prospec Latest Developments
Table 100. Cusabio Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 101. Cusabio Toxoplasma Gondii Recombinant Antigen Product Offered
Table 102. Cusabio Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Cusabio Main Business
Table 104. Cusabio Latest Developments
Table 105. Abbexa Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 106. Abbexa Toxoplasma Gondii Recombinant Antigen Product Offered
Table 107. Abbexa Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Abbexa Main Business
Table 109. Abbexa Latest Developments
Table 1. Toxoplasma Gondii Recombinant Antigen Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Toxoplasma Gondii Recombinant Antigen Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Full-Length Antigen
Table 4. Major Players of Truncated Antigen
Table 5. Toxoplasma Gondii Recombinant Antigen Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type (2021-2026)
Table 8. Toxoplasma Gondii Recombinant Antigen Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application (2021-2026)
Table 11. Global Toxoplasma Gondii Recombinant Antigen Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Toxoplasma Gondii Recombinant Antigen Revenue Market Share by Player (2021-2026)
Table 13. Toxoplasma Gondii Recombinant Antigen Key Players Head office and Products Offered
Table 14. Toxoplasma Gondii Recombinant Antigen Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Toxoplasma Gondii Recombinant Antigen Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Region (2021-2026)
Table 19. Global Toxoplasma Gondii Recombinant Antigen Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Toxoplasma Gondii Recombinant Antigen Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Toxoplasma Gondii Recombinant Antigen Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Country (2021-2026)
Table 23. Americas Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type (2021-2026)
Table 25. Americas Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application (2021-2026)
Table 27. APAC Toxoplasma Gondii Recombinant Antigen Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Region (2021-2026)
Table 29. APAC Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Toxoplasma Gondii Recombinant Antigen Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Country (2021-2026)
Table 33. Europe Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Toxoplasma Gondii Recombinant Antigen
Table 39. Key Market Challenges & Risks of Toxoplasma Gondii Recombinant Antigen
Table 40. Key Industry Trends of Toxoplasma Gondii Recombinant Antigen
Table 41. Global Toxoplasma Gondii Recombinant Antigen Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Toxoplasma Gondii Recombinant Antigen Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Toxoplasma Gondii Recombinant Antigen Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Rekom Biotech Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 46. Rekom Biotech Toxoplasma Gondii Recombinant Antigen Product Offered
Table 47. Rekom Biotech Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Rekom Biotech Main Business
Table 49. Rekom Biotech Latest Developments
Table 50. Roche Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 51. Roche Toxoplasma Gondii Recombinant Antigen Product Offered
Table 52. Roche Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Roche Main Business
Table 54. Roche Latest Developments
Table 55. Thermal Fisher Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 56. Thermal Fisher Toxoplasma Gondii Recombinant Antigen Product Offered
Table 57. Thermal Fisher Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Thermal Fisher Main Business
Table 59. Thermal Fisher Latest Developments
Table 60. Bio-Rad Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 61. Bio-Rad Toxoplasma Gondii Recombinant Antigen Product Offered
Table 62. Bio-Rad Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Bio-Rad Main Business
Table 64. Bio-Rad Latest Developments
Table 65. Abcam Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 66. Abcam Toxoplasma Gondii Recombinant Antigen Product Offered
Table 67. Abcam Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Abcam Main Business
Table 69. Abcam Latest Developments
Table 70. Meridian Bioscience Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 71. Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Product Offered
Table 72. Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Meridian Bioscience Main Business
Table 74. Meridian Bioscience Latest Developments
Table 75. Fapon Biotech Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 76. Fapon Biotech Toxoplasma Gondii Recombinant Antigen Product Offered
Table 77. Fapon Biotech Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Fapon Biotech Main Business
Table 79. Fapon Biotech Latest Developments
Table 80. ViroGen Corporation Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 81. ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Product Offered
Table 82. ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. ViroGen Corporation Main Business
Table 84. ViroGen Corporation Latest Developments
Table 85. Medix Biochemica Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 86. Medix Biochemica Toxoplasma Gondii Recombinant Antigen Product Offered
Table 87. Medix Biochemica Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Medix Biochemica Main Business
Table 89. Medix Biochemica Latest Developments
Table 90. Creative Diagnostics Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 91. Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Product Offered
Table 92. Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Creative Diagnostics Main Business
Table 94. Creative Diagnostics Latest Developments
Table 95. Prospec Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 96. Prospec Toxoplasma Gondii Recombinant Antigen Product Offered
Table 97. Prospec Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Prospec Main Business
Table 99. Prospec Latest Developments
Table 100. Cusabio Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 101. Cusabio Toxoplasma Gondii Recombinant Antigen Product Offered
Table 102. Cusabio Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Cusabio Main Business
Table 104. Cusabio Latest Developments
Table 105. Abbexa Details, Company Type, Toxoplasma Gondii Recombinant Antigen Area Served and Its Competitors
Table 106. Abbexa Toxoplasma Gondii Recombinant Antigen Product Offered
Table 107. Abbexa Toxoplasma Gondii Recombinant Antigen Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Abbexa Main Business
Table 109. Abbexa Latest Developments
LIST OF FIGURES
Figure 1. Toxoplasma Gondii Recombinant Antigen Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Toxoplasma Gondii Recombinant Antigen Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Toxoplasma Gondii Recombinant Antigen Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Toxoplasma Gondii Recombinant Antigen Sales Market Share by Country/Region (2025)
Figure 8. Toxoplasma Gondii Recombinant Antigen Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type in 2025
Figure 10. Toxoplasma Gondii Recombinant Antigen in In Vitro Diagnostics
Figure 11. Global Toxoplasma Gondii Recombinant Antigen Market: In Vitro Diagnostics (2021-2026) & ($ millions)
Figure 12. Toxoplasma Gondii Recombinant Antigen in Vaccine Development
Figure 13. Global Toxoplasma Gondii Recombinant Antigen Market: Vaccine Development (2021-2026) & ($ millions)
Figure 14. Toxoplasma Gondii Recombinant Antigen in Others
Figure 15. Global Toxoplasma Gondii Recombinant Antigen Market: Others (2021-2026) & ($ millions)
Figure 16. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application in 2025
Figure 17. Global Toxoplasma Gondii Recombinant Antigen Revenue Market Share by Player in 2025
Figure 18. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Region (2021-2026)
Figure 19. Americas Toxoplasma Gondii Recombinant Antigen Market Size 2021-2026 ($ millions)
Figure 20. APAC Toxoplasma Gondii Recombinant Antigen Market Size 2021-2026 ($ millions)
Figure 21. Europe Toxoplasma Gondii Recombinant Antigen Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size 2021-2026 ($ millions)
Figure 23. Americas Toxoplasma Gondii Recombinant Antigen Value Market Share by Country in 2025
Figure 24. United States Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Region in 2025
Figure 29. APAC Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type (2021-2026)
Figure 30. APAC Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application (2021-2026)
Figure 31. China Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 35. India Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Country in 2025
Figure 38. Europe Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type (2021-2026)
Figure 39. Europe Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application (2021-2026)
Figure 40. Germany Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 41. France Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 54. APAC Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 55. Europe Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 57. United States Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 58. Canada Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 59. Mexico Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 60. Brazil Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 61. China Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 62. Japan Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 63. Korea Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 65. India Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 66. Australia Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 67. Germany Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 68. France Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 69. UK Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 70. Italy Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 71. Russia Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 72. Egypt Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 73. South Africa Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 74. Israel Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 75. Turkey Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 76. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 1. Toxoplasma Gondii Recombinant Antigen Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Toxoplasma Gondii Recombinant Antigen Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Toxoplasma Gondii Recombinant Antigen Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Toxoplasma Gondii Recombinant Antigen Sales Market Share by Country/Region (2025)
Figure 8. Toxoplasma Gondii Recombinant Antigen Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type in 2025
Figure 10. Toxoplasma Gondii Recombinant Antigen in In Vitro Diagnostics
Figure 11. Global Toxoplasma Gondii Recombinant Antigen Market: In Vitro Diagnostics (2021-2026) & ($ millions)
Figure 12. Toxoplasma Gondii Recombinant Antigen in Vaccine Development
Figure 13. Global Toxoplasma Gondii Recombinant Antigen Market: Vaccine Development (2021-2026) & ($ millions)
Figure 14. Toxoplasma Gondii Recombinant Antigen in Others
Figure 15. Global Toxoplasma Gondii Recombinant Antigen Market: Others (2021-2026) & ($ millions)
Figure 16. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application in 2025
Figure 17. Global Toxoplasma Gondii Recombinant Antigen Revenue Market Share by Player in 2025
Figure 18. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Region (2021-2026)
Figure 19. Americas Toxoplasma Gondii Recombinant Antigen Market Size 2021-2026 ($ millions)
Figure 20. APAC Toxoplasma Gondii Recombinant Antigen Market Size 2021-2026 ($ millions)
Figure 21. Europe Toxoplasma Gondii Recombinant Antigen Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size 2021-2026 ($ millions)
Figure 23. Americas Toxoplasma Gondii Recombinant Antigen Value Market Share by Country in 2025
Figure 24. United States Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Region in 2025
Figure 29. APAC Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type (2021-2026)
Figure 30. APAC Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application (2021-2026)
Figure 31. China Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 35. India Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Country in 2025
Figure 38. Europe Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type (2021-2026)
Figure 39. Europe Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application (2021-2026)
Figure 40. Germany Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 41. France Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Toxoplasma Gondii Recombinant Antigen Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 54. APAC Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 55. Europe Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 57. United States Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 58. Canada Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 59. Mexico Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 60. Brazil Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 61. China Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 62. Japan Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 63. Korea Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 65. India Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 66. Australia Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 67. Germany Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 68. France Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 69. UK Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 70. Italy Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 71. Russia Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 72. Egypt Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 73. South Africa Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 74. Israel Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 75. Turkey Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
Figure 76. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Toxoplasma Gondii Recombinant Antigen Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Toxoplasma Gondii Recombinant Antigen Market Size 2027-2032 ($ millions)
